Hong Kong stocks fluctuate | PAG Pharmaceuticals-B (02565.HK) surged more than 15% in the afternoon, breaking through the peak PB-119 to treat T2DM is expected to receive NDA approval within the year
According to the Wisdom Financial APP, BeiGene Biomedical-B (02565.HK) surged more than 15% in the afternoon, reaching a high of 24.14 Hong Kong dollars, setting a new record high. As of the time of publication, it was up 14.82% to 23.24 Hong Kong dollars, with a trading volume of 20.3186 million Hong Kong dollars.
Latest